Prescriber's Letter | Unbiased Medication Updates & CME

Current Issue

December 2023 Issue

Answer Common Questions About First-Line BP Meds

Questions continue to pop up about choosing BP meds for initial treatment of uncomplicated hypertension...

Resources

Chart: Treatment of Hypertension
Chart: Comparison of Commonly Used Diuretics
Chart: Comparison of Calcium Channel Blockers
Chart: Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors

Use a Conservative Approach for Most Inpatient Hypertension

Newer data will put a spotlight on appropriate management of BP elevations during a hospitalization...

Compare Nalmefene and Naloxone for Opioid Overdose Reversal

New Rx nalmefene nasal spray (Opvee) will join naloxone as an option to reverse opioid overdose...

Navigate Risk of Ketoacidosis Due to an SGLT2 Inhibitor

You’ll need to know how to manage the risk of ketoacidosis due to SGLT2 inhibitors (dapagliflozin, etc)...

GO TO FULL ISSUE

CE & Training

PODCAST CE: Managing Chronic Coronary Disease

CE-IN-THE-LETTER: Prescriber Insights December 2023

LIVE CE: Emerging Recommendations Panel December 2023

GO TO CE & TRAINING ORGANIZER

Free Clinical Resources

Preventing RSV

How to Switch Insulin Products

Drugs for Type 2 Diabetes

GO TO ALL CLINICAL RESOURCES

What is Prescriber's Letter?

Prescriber's Letter is the fastest, most trustworthy way to find out how drug therapy changes should fit into your practice, all while earning monthly CME credit. It's 100% free from financial support of the pharma industry. Learn more >

Unlock More

Prescriber's Letter is one of many medication advisory, CE, and training solutions from TRC Healthcare. We support prescribers of all kinds, at all stages of their career.

If you're a training decision-maker, learn more about our:

Solutions for Group Practices
Patient Simulations to Standardize Clinical Practice